Cart
sales@molnova.com
Brodimoprim
CAS No. 56518-41-3
Brodimoprim( Ro 10-5970 )
Catalog No. M27177 CAS No. 56518-41-3
Brodimoprim is an inhibitor of dihydrofolate reductase(DHFR). Brodimoprim is also a long-acting broad-spectrum antibacterial agent characterized by a good pharmacokinetic profile.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 77 | In Stock |
|
| 10MG | 123 | In Stock |
|
| 25MG | 211 | In Stock |
|
| 50MG | 310 | In Stock |
|
| 100MG | 445 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBrodimoprim
-
NoteResearch use only, not for human use.
-
Brief DescriptionBrodimoprim is an inhibitor of dihydrofolate reductase(DHFR). Brodimoprim is also a long-acting broad-spectrum antibacterial agent characterized by a good pharmacokinetic profile.
-
DescriptionBrodimoprim is an inhibitor of dihydrofolate reductase(DHFR). Brodimoprim is also a long-acting broad-spectrum antibacterial agent characterized by a good pharmacokinetic profile.
-
In Vitro——
-
In Vivo——
-
SynonymsRo 10-5970
-
PathwayCell Cycle/DNA Damage
-
TargetDHFR
-
RecptorACAT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number56518-41-3
-
Formula Weight339.193
-
Molecular FormulaC13H15BrN4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (98.26 mM)
-
SMILESCOc1cc(Cc2cnc(N)nc2N)cc(OC)c1Br
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.M.J. Ashton, et al. RP 70676: A potent systematically available inhibitor of acyl-CoA:cholesterol O-acyl transferase (ACAT). Bioorganic & Medicinal Chemistry Letters Volume 2, Issue 5, 1992, Pages 375-380.
molnova catalog
related products
-
P 218
P 218 is a novel DHFR inhibitor with antimalarial activity and antifolate effects and can be used to study Buruli ulcer.
-
Sulfameter
Sulfameter(Bayrena) is a long-acting sulfonamide antibacterial.
-
DS18561882
DS18561882 is an orally available, selective and potent inhibitor of methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) with antitumor activity, inhibits MTHFD1 activity and can be used in the study of breast cancer.
